A group including CD&R and existing lenders, including HPS Investment Partners, agreed to a deal that will inject $225 ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced that Bill Galvin has been engaged as an Operating Advisor to ...

Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

The plan for Public Investment Bank to take a 1% stake in Opella, for about EUR 150M, or $162.98M, came through a tri-party agreement between Sanofi, the French state and CD&R and was approved by ...

Vialto Partners, a provider of tax and immigration services, has agreed to restructure its debt a little more than two years after the company spun out of PricewaterhouseCoopers and was acquired by ...